Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             150 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case with isolated growth hormone deficiency caused by compound heterozygous mutations in GH-1: A novel missense mutation in the initiation codon and a 7.6kb deletion Hayashi, Yoshitaka
 2007
 3 p. 249-253
5 p.
 artikel
2 Acute resistance exercise stimulates sex-specific dimeric immunoreactive growth hormone responses Luk, Hui Ying
 2015
 3 p. 136-140
5 p.
 artikel
3 Aging phenotype and its relationship with IGF-I gene promoter polymorphisms in elderly people living in Catalonia Mora, Mireia
 2011
 3 p. 174-180
7 p.
 artikel
4 Aims & Scope/Editorial Board 2009
 3 p. i-
1 p.
 artikel
5 Aims & Scope/Editorial Board 2010
 3 p. i-
1 p.
 artikel
6 Aims & Scope/Editorial Board 2006
 3 p. i-
1 p.
 artikel
7 Aims; Scope/Editorial Board 2004
 3 p. i-
1 p.
 artikel
8 Aims & Scope/Editorial Board 2008
 3 p. i-
1 p.
 artikel
9 Aims&scope/Editorial Boardi 2007
 3 p. i-
1 p.
 artikel
10 A liver specific gene that is expressed in growth hormone transgenic mice and in normal female mice as a function of age Tiong, Jean D.R.
 2006
 3 p. 145-156
12 p.
 artikel
11 Alternative splicing of insulin-like growth factor I mRNA is developmentally regulated in the rat and mouse with preferential exon 2 usage in the mouse Lin, Wen-wen
 1998
 3 p. 225-233
9 p.
 artikel
12 Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy Fernholm, R.
 2009
 3 p. 206-211
6 p.
 artikel
13 A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men Svensson, J.
 2000
 3 p. 118-126
9 p.
 artikel
14 An N-terminal fragment of insulin-like growth factor binding protein-3 (IGFBP-3) induces apoptosis in human prostate cancer cells in an IGF-independent manner Shahjee, H.
 2008
 3 p. 188-197
10 p.
 artikel
15 An ocular view of the IGF–IGFBP system Nguyen, Dung V.
 2013
 3 p. 45-52
8 p.
 artikel
16 A novel GH-1 gene mutation (GH-P59L) causes partial GH deficiency type II combined with bioinactive GH syndrome Petkovic, Vibor
 2011
 3 p. 160-166
7 p.
 artikel
17 Appearance of insulin and insulin-like growth factor-I (IGF-I) receptors throughout the ontogeny of brown trout (Salmo trutta fario) Maestro, M.A.
 1998
 3 p. 195-204
10 p.
 artikel
18 A quantitative PCR measurement of messenger RNA expression of IGF-I, IGF-II and IGFBP-5 in human skeletal muscle Schimke, Jill M.Coenen
 1999
 3 p. 179-186
8 p.
 artikel
19 Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk Belobrajdic, Damien P.
 2008
 3 p. 198-204
7 p.
 artikel
20 Assessment of hydration by means of bioelectrical impedance and arm muscle area during growth hormone (GH) replacement therapy: A prospective study of 130 GH-deficient patients Badre-Esfahani, Sara
 2007
 3 p. 227-233
7 p.
 artikel
21 Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus Akturk, Mujde
 2007
 3 p. 186-193
8 p.
 artikel
22 Associations of the IGF/IGFBP axis and respiratory diseases in neonatal patients during the first 6 months of life Hübler, Axel
 2006
 3 p. 185-192
8 p.
 artikel
23 Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome Sode-Carlsen, Rasmus
 2010
 3 p. 179-184
6 p.
 artikel
24 Cardiac IGF-I manipulation by growth hormone following myocardial infarction Matthews, K.G
 2004
 3 p. 251-260
10 p.
 artikel
25 Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II) Binder, G.
 2007
 3 p. 242-248
7 p.
 artikel
26 Characterisation of insulin-like growth factor receptors and insulin receptors in the human placenta using lectin affinity methods Masnikosa, Romana
 2006
 3 p. 174-184
11 p.
 artikel
27 Circulating IGF-I is associated with fitness and health outcomes in a population of 846 young healthy men Nindl, Bradley C.
 2011
 3 p. 124-128
5 p.
 artikel
28 Circulating insulin-like growth factors (IGF-I and -II) and IGF binding proteins in divergently selected Fat or Lean chickens: effect of prolonged fasting Beccavin, C.
 1999
 3 p. 187-194
8 p.
 artikel
29 Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes Jeyaratnaganthan, Nilani
 2010
 3 p. 185-191
7 p.
 artikel
30 Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels Temmerman, L.
 2010
 3 p. 255-263
9 p.
 artikel
31 Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients Wassenaar, M.J.E.
 2010
 3 p. 226-233
8 p.
 artikel
32 Combination treatment with somatostatin analogues and pegvisomant in acromegaly Neggers, S.J.C.M.M.
 2011
 3 p. 129-133
5 p.
 artikel
33 Consensus statement from an international collaborative 2007
 3 p. 177-178
2 p.
 artikel
34 Contrasting bone effects of temporary versus permanent IGFBP administration in rodents Hoeflich, Andreas
 2008
 3 p. 181-187
7 p.
 artikel
35 Cyclic AMP agonists increase levels of insulin-like growth factor (IGF) binding protein-6 in PC12 rat phaeochromocytoma cells Bach, Leon A.
 1998
 3 p. 265-271
7 p.
 artikel
36 Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro Barreca, A.
 1998
 3 p. 217-223
7 p.
 artikel
37 Detection of growth hormone abuse in sport Powrie, J.K.
 2007
 3 p. 220-226
7 p.
 artikel
38 Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth factor-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes Beauloye, V.
 1999
 3 p. 205-211
7 p.
 artikel
39 Diagnosis and management of growth hormone deficiency in childhood and adolescence Sizonenko, Pierre C
 2001
 3 p. 137-165
29 p.
 artikel
40 Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells Conover, Cheryl A.
 2008
 3 p. 213-220
8 p.
 artikel
41 Dose-dependent changes in body composition during growth hormone (GH) treatment in Japanese patients with adult GH deficiency: A randomized, placebo-controlled trial Chihara, Kazuo
 2010
 3 p. 205-211
7 p.
 artikel
42 Editorial Sönksen, Peter
 2000
 3 p. 107-110
4 p.
 artikel
43 Editorial Board 2002
 3 p. i-
1 p.
 artikel
44 Editorial board 2005
 3 p. i-
1 p.
 artikel
45 Editorial Board 2015
 3 p. i-
1 p.
 artikel
46 Editorial Board 2013
 3 p. i-
1 p.
 artikel
47 Editorial Board 2011
 3 p. i-
1 p.
 artikel
48 Effect of circulating growth hormone on muscle IGF-I protein concentration in female mice with growth hormone receptor gene disruption Kraemer, William J.
 2009
 3 p. 242-244
3 p.
 artikel
49 Effect of environment on growth: Auxological and hormonal parameters in African and Italian children Boschetti, Mara
 2009
 3 p. 238-241
4 p.
 artikel
50 Effects of growth hormone treatment in adults with Prader–Willi syndrome Butler, M.G.
 2013
 3 p. 81-87
7 p.
 artikel
51 Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature Guevara-Aguirre, Jaime
 2007
 3 p. 261-264
4 p.
 artikel
52 Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro Mochizuki, Tomoko
 2006
 3 p. 202-210
9 p.
 artikel
53 Effects of lifestyle on plasma levels of the IGF system and the antioxidants coenzyme Q10 and vitamin E in Kenyan rural and urban populations Theuri, G.
 2013
 3 p. 68-75
8 p.
 artikel
54 Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan’s syndrome Tanriverdi, F.
 2005
 3 p. 231-237
7 p.
 artikel
55 Erratum 2001
 3 p. 198-199
2 p.
 artikel
56 Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users Graham, Michael R.
 2007
 3 p. 201-209
9 p.
 artikel
57 Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system Hattori, Naoki
 2009
 3 p. 187-197
11 p.
 artikel
58 Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): Correlation with serum IGFBP-3 levels and growth in short children born small for gestational age Kaay, D.C.M. van der
 2009
 3 p. 198-205
8 p.
 artikel
59 Genetic strategies for elucidating insulin-like growth factor action in bone Clemens, Thomas L.
 2004
 3 p. 195-199
5 p.
 artikel
60 GH receptor blocker administration and muscle–tendon collagen synthesis in humans Nielsen, Rie Harboe
 2011
 3 p. 140-145
6 p.
 artikel
61 Growth hormone administration can improve growth in glucocorticoid-injected rats without affecting the lymphocytopenic effect of the glucocorticoid Ørtoft, G.
 1998
 3 p. 251-264
14 p.
 artikel
62 Growth hormone and adipose tissue: Beyond the adipocyte Berryman, Darlene E.
 2011
 3 p. 113-123
11 p.
 artikel
63 Growth hormone binding protein and maternal body mass index in relation to placental growth hormone and insulin requirements during pregnancy in type 1 diabetic women Fuglsang, Jens
 2005
 3 p. 223-230
8 p.
 artikel
64 Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction Akin, Fulya
 2009
 3 p. 252-255
4 p.
 artikel
65 Growth hormone promotes proliferation of adult neurosphere cultures McLenachan, S.
 2009
 3 p. 212-218
7 p.
 artikel
66 Growth hormone receptor d3-variant, insulin-like growth factor binding protein-1 –575G/A polymorphism and postnatal catch-up growth: Association with parameters of glucose homeostasis in former extremely low birth weight preterm infants Schreiner, Felix
 2010
 3 p. 201-204
4 p.
 artikel
67 Growth hormone treatment and type 2 diabetes Kohno, H.
 2001
 3 p. 196-197
2 p.
 artikel
68 GRS 2000 Abstracts 2000
 3 p. 129-186
58 p.
 artikel
69 Heterozygous mutation in the WSXWS equivalent motif of the growth hormone receptor in a child with poor response to growth hormone therapy Tauber, M.T.
 1998
 3 p. 211-216
6 p.
 artikel
70 Hormonal and metabolic responses to repeated cycling sprints under different hypoxic conditions Kon, Michihiro
 2015
 3 p. 121-126
6 p.
 artikel
71 Hypopituitarism following traumatic brain injury Popovic, V.
 2005
 3 p. 177-184
8 p.
 artikel
72 Identification of N-linked oligosaccharides of rat insulin-like growth factor binding protein-4 Chelius, Dirk
 2002
 3 p. 169-177
9 p.
 artikel
73 IGFBP-6 five years on; not so ‘forgotten’? Bach, Leon A.
 2005
 3 p. 185-192
8 p.
 artikel
74 IGFBP-2/PTEN: A critical interaction for tumours and for general physiology? Zeng, Li
 2015
 3 p. 103-107
5 p.
 artikel
75 IGF-I, IGFBP-3 and ALS generation test in Turner syndrome Pessoa de Queiroz, Andréa Noronha
 2007
 3 p. 254-260
7 p.
 artikel
76 IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function Scheinowitz, Mickey
 2009
 3 p. 280-282
3 p.
 artikel
77 IGF-IR/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children Iñiguez, German
 2009
 3 p. 256-261
6 p.
 artikel
78 IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes Fukuoka, Hidenori
 2010
 3 p. 212-219
8 p.
 artikel
79 IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients Nindl, Bradley C.
 2004
 3 p. 245-250
6 p.
 artikel
80 Impact of the GH–cortisol ratio on the age-dependent changes in body composition Nass, R
 2002
 3 p. 147-161
15 p.
 artikel
81 Inactivation of insulin-like-growth factors diminished the anabolic effects of pregnancy-associated plasma protein-A (PAPP-A) on bone in mice Phang, David
 2010
 3 p. 192-200
9 p.
 artikel
82 Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month’s treatment with supraphysiological doses of growth hormone Ehrnborg, Christer
 2007
 3 p. 234-241
8 p.
 artikel
83 Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: Responses of molecular mass variants Kraemer, William J.
 2008
 3 p. 238-244
7 p.
 artikel
84 Insulin-like growth factor binding protein-4 expression is dependent on the carbohydrate in the media in HT-29 cells Corkins, Mark R
 2002
 3 p. 184-192
9 p.
 artikel
85 Insulin-like growth factor binding protein-3 gene methylation and protein expression in gastric adenocarcinoma Gigek, Carolina Oliveira
 2010
 3 p. 234-238
5 p.
 artikel
86 Insulin-like growth factor binding protein-5 in osteogenesis: Facilitator or inhibitor? Mukherjee, Aditi
 2007
 3 p. 179-185
7 p.
 artikel
87 Insulin-like growth factor binding protein-3 is a novel mediator of apoptosis in insulin-secreting cells Shim, Melanie L
 2004
 3 p. 216-225
10 p.
 artikel
88 Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis Vasylyeva, Tetyana L.
 2005
 3 p. 207-214
8 p.
 artikel
89 Insulin-like growth factor-I (IGF-I): Solution properties and NMR chemical shift assignments near physiological pH Kuang, Zhihe
 2009
 3 p. 226-231
6 p.
 artikel
90 Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African–American women Kalla Singh, S.
 2010
 3 p. 245-254
10 p.
 artikel
91 Interleukin-5 potentiates the growth response of Caco-2 cells to IGF-II: A role in colonic carcinogenesis complicating ulcerative colitis? Makins, Richard
 2005
 3 p. 215-222
8 p.
 artikel
92 Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin Vindeløv, Signe Diness
 2011
 3 p. 134-139
6 p.
 artikel
93 Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly Biermasz, Nienke R.
 2005
 3 p. 200-206
7 p.
 artikel
94 Is growth hormone stimulation testing in children still appropriate? Gandrud, Laura M
 2004
 3 p. 185-194
10 p.
 artikel
95 Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease Kuan, Ying
 2009
 3 p. 219-225
7 p.
 artikel
96 Lack of insulin-like growth factor binding protein-3 protease activation by venous cannulation Gustafsson, S.
 2005
 3 p. 238-242
5 p.
 artikel
97 Lies, damn lies and statistics Sonksen, Peter H.
 2005
 3 p. 173-176
4 p.
 artikel
98 Local feedback loop of ghrelin-GH in the pig ovary: Action on estradiol secretion, aromatase activity and cell apoptosis Rak, Agnieszka
 2008
 3 p. 221-227
7 p.
 artikel
99 Long-term physical training increases liver IGF-I in diabetic rats Leme, J.A.C.A.
 2009
 3 p. 262-266
5 p.
 artikel
100 Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults Devin, Jessica K.
 2008
 3 p. 253-263
11 p.
 artikel
101 Maternal insulin-like growth factor 1 and 2 differentially affect the renin–angiotensin system during pregnancy in the guinea pig Standen, Prue
 2015
 3 p. 141-147
7 p.
 artikel
102 MMP-2 in the left rat ventricle is increased by growth hormone Brüel, Annemarie
 2006
 3 p. 193-201
9 p.
 artikel
103 Modulation of rat pituitary growth hormone by 670nm light Hymer, W.C.
 2009
 3 p. 274-279
6 p.
 artikel
104 mRNA and protein localization of the IGF system during mouse embryonic development in areas with apoptosis Kleffens, M.van
 1999
 3 p. 195-204
10 p.
 artikel
105 Muscle insulin-like growth factor-I (IGF-I) receptors in chickens with high or low body weight: effects of age and muscle fibre type Oudin, A.
 1998
 3 p. 243-250
8 p.
 artikel
106 Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and -4 Brandt, Katrin
 2011
 3 p. 167-173
7 p.
 artikel
107 Ovine placental lactogen and human growth hormone bind to different regions of the same receptors Longhi, S.A.
 1999
 3 p. 157-164
8 p.
 artikel
108 Perioperative treatment with human growth hormone down-regulates apoptosis and increases superoxide production in PMN from patients undergoing infrarenal abdominal aortic aneurysm repair Decker, Dorothee
 2005
 3 p. 193-199
7 p.
 artikel
109 Peripheral growth hormone induces cell proliferation in the intact adult rat brain David Åberg, N.
 2010
 3 p. 264-269
6 p.
 artikel
110 Pharmacodynamic evaluation of a PEGylated analogue of human growth hormone releasing factor in rats and pigs D'Antonio, M
 2004
 3 p. 226-234
9 p.
 artikel
111 Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers Garcia, José M.
 2009
 3 p. 267-273
7 p.
 artikel
112 Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes Wilhelm, Franziska
 2015
 3 p. 115-120
6 p.
 artikel
113 Pituitary choriocarcinoma in an adolescent male: Tumor-derived CG and GH delay diagnosis Wildi-Runge, S.
 2011
 3 p. 181-184
4 p.
 artikel
114 Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency Rizzo, Manfredi
 2008
 3 p. 264-266
3 p.
 artikel
115 Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP Glad, Camilla A.M.
 2010
 3 p. 270-273
4 p.
 artikel
116 Recommendations for nomenclature of the insulin-like growth factor binding protein (IGFBP) superfamily Baxter, R.C.
 1998
 3 p. 273-274
2 p.
 artikel
117 Reduced GLUT1 expression in Igf1–/– null oocytes and follicles Zhou, J.
 2000
 3 p. 111-117
7 p.
 artikel
118 Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: Results of the Study of Health in Pomerania (SHIP) Friedrich, Nele
 2008
 3 p. 228-237
10 p.
 artikel
119 Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor Makimura, H.
 2011
 3 p. 155-159
5 p.
 artikel
120 Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3 Safarinejad, Mohammad Reza
 2011
 3 p. 146-154
9 p.
 artikel
121 Rskα-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: Impact on regeneration, denervation and muscular dystrophy Shavlakadze, T.
 2006
 3 p. 157-173
17 p.
 artikel
122 Safety aspects of pharmacological GH therapy in adults Carroll, Paul V.
 2001
 3 p. 166-172
7 p.
 artikel
123 Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature Gascoin-Lachambre, G.
 2007
 3 p. 194-200
7 p.
 artikel
124 short-term administration of insulin-like growth factor I (IGF-1) does not induce myocardial IGF-1 resistance Ren, Jun
 2002
 3 p. 162-168
7 p.
 artikel
125 Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction Tivesten, Å.
 2001
 3 p. 187-195
9 p.
 artikel
126 Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone Wu, Zida
 2010
 3 p. 239-244
6 p.
 artikel
127 Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis Conover, Cheryl A
 2002
 3 p. 178-183
6 p.
 artikel
128 Suppressors of cytokine signalling and regulation of growth hormone action Greenhalgh, Christopher J.
 2004
 3 p. 200-206
7 p.
 artikel
129 Survival and cellular immune functions in septic mice treated with growth hormone (GH) and insulin-like growth factor-I (IGF-I) Schmitz, Daniel
 2008
 3 p. 245-252
8 p.
 artikel
130 Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing Weiss, Stefan
 2008
 3 p. 205-212
8 p.
 artikel
131 The effect of acute application of pegvisomant alone and in combination with octreotide on endogenous GH levels during a 6-h test in patients with acromegaly on constant pegvisomant treatment Roemmler, J.
 2009
 3 p. 245-251
7 p.
 artikel
132 The effect of acute insulin-like growth factor-II administration on glucose metabolism in the rat Burvin, Ram
 1998
 3 p. 205-210
6 p.
 artikel
133 The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy O’Neal, D.N.
 1999
 3 p. 165-173
9 p.
 artikel
134 The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides Renehan, Andrew G.
 2007
 3 p. 210-219
10 p.
 artikel
135 The effects of two weeks of recombinant growth hormone administration on the response of IGF-I and N-terminal pro-peptide of collagen type III (P-III-NP) during a single bout of high resistance exercise in resistance trained young men Velloso, C.P.
 2013
 3 p. 76-80
5 p.
 artikel
136 The growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver Hellgren, Gunnel
 1999
 3 p. 212-218
7 p.
 artikel
137 The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children Hellgren, G.
 2015
 3 p. 127-135
9 p.
 artikel
138 The IGF-II enigma Holly, Jeff M.P.
 1998
 3 p. 183-184
2 p.
 artikel
139 The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency Deepak, D.
 2010
 3 p. 220-225
6 p.
 artikel
140 The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment Zimmermann-Belsing, T.
 2004
 3 p. 235-244
10 p.
 artikel
141 The robustness of diagnostic tests for GH deficiency in adults Andersen, Marianne
 2015
 3 p. 108-114
7 p.
 artikel
142 The role of growth hormone in fetal development Waters, M.J
 2002
 3 p. 137-146
10 p.
 artikel
143 The role of human growth hormone's C-terminal disulfide bridge Junnila, R.K.
 2013
 3 p. 62-67
6 p.
 artikel
144 The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy Sharples, Adam P.
 2013
 3 p. 53-61
9 p.
 artikel
145 The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues Dubreuil, P
 2001
 3 p. 173-186
14 p.
 artikel
146 Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption Svensson, Johan
 2004
 3 p. 207-215
9 p.
 artikel
147 Thyroid hormones are involved in insulin-like growth factor-I (IGF-I) production by stimulating hepatic growth hormone receptor (GHR) gene expression in the chicken Tsukada, A.
 1998
 3 p. 235-242
8 p.
 artikel
148 Tumor necrosis factor α and interferon γ– induced cell growth arrest is mediated via insulin-like growth factor binding protein-3 Katz, J
 1999
 3 p. 174-178
5 p.
 artikel
149 Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH–IGF) axis gene expression in human fetal epiphyseal chondrocytes Fernández-Cancio, M.
 2009
 3 p. 232-237
6 p.
 artikel
150 What is the function of IGF-II in postnatal life? Answers from transgenic mouse models Wolf, Eckhard
 1998
 3 p. 185-193
9 p.
 artikel
                             150 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland